Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ergotamine measurement |
Component |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Product containing ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Dihydroergotamine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Dihydroergotamine mesylate 4mg/1mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Dihydroergotamine mesylate 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Ergotamine tartrate (substance) |
Is a |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing dihydroergotamine mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Ergotamine withdrawal |
Causative agent (attribute) |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Product containing dihydroergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing dihydroergotamine mesylate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Oxytocin and ergometrine adverse reaction |
Causative agent (attribute) |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Dihydroergotamine mesilate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Dihydroergotamine (substance) |
Is a |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Ergotamine + caffeine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Ergotamine tartrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
|
Product containing ergotamine in sublingual dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Product containing caffeine and ergotamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
3 |
Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
3 |
Caffeine- and ergotamine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Ergotamine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
3 |
Product containing only caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Ergotamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Caffeine and ergotamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
2 |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
3 |
Ergotamine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Ergotamine dependence (disorder) |
Causative agent (attribute) |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |
Medication overuse headache caused by ergotamine (finding) |
Causative agent (attribute) |
True |
Ergotamine (substance) |
Inferred relationship |
Some |
1 |